KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Income towards Parent Company (2016 - 2025)

Opko Health (OPK) has disclosed Income towards Parent Company for 16 consecutive years, with -$46.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company fell 260.66% year-over-year to -$46.2 million, compared with a TTM value of -$240.6 million through Dec 2025, down 525.67%, and an annual FY2025 reading of -$240.6 million, down 525.68% over the prior year.
  • Income towards Parent Company was -$46.2 million for Q4 2025 at Opko Health, down from $21.6 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $31.1 million in Q1 2021 and bottomed at -$159.6 million in Q4 2022.
  • Average Income towards Parent Company over 5 years is -$45.0 million, with a median of -$50.8 million recorded in 2022.
  • The sharpest move saw Income towards Parent Company soared 152.75% in 2021, then tumbled 1340.62% in 2025.
  • Year by year, Income towards Parent Company stood at -$73.3 million in 2021, then plummeted by 117.72% to -$159.6 million in 2022, then soared by 58.44% to -$66.3 million in 2023, then skyrocketed by 143.39% to $28.8 million in 2024, then plummeted by 260.66% to -$46.2 million in 2025.
  • Business Quant data shows Income towards Parent Company for OPK at -$46.2 million in Q4 2025, $21.6 million in Q3 2025, and -$148.4 million in Q2 2025.